325
Views
10
CrossRef citations to date
0
Altmetric
Review

Preoperative psychological evaluation of transplant patients: challenges and solutions

&
Pages 35-43 | Published online: 26 Jun 2015

References

  • Petit F, Minns AB, Dubernard JM, Hettiaratchy S, Lee WP. Composite tissue allotransplantation and reconstructive surgery: first clinical applications. Ann Plast Surg. 2003;237:19–25.
  • Hettiaratchy S, Randolph MA, Andrew Lee WP. Long-term consideration of hand transplantation. Transplantation. 2003;75:1605.
  • Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87:1497–1504.
  • Kumnig M, Jowsey SG, DiMartini A. Psychological aspects of hand transplantation. Curr Opin Organ Transplant. 2014;19:188–195.
  • Kumnig M, Jowsey SG, Rumpold G, et al. The psychological assessment of candidates for reconstructive hand transplantation. Transpl Int. 2012;25:573–585.
  • Jowsey SG, Taylor M, Schneekloth TD, Clark MM. Psychosocial challanges in transplantation. J Psychiatr Pract. 2001;7:404–414.
  • Delmonico FL. A report of the Amsterdam Forum on the care of the live kidney donor: data and medical guidelines. Transplantation. 2005;79:S53–S66.
  • Kumnig M, Jowsey SG, Moreno E, Brandacher G, Azari K, Rumpold G. An overview of psychosocial assessment procedures in reconstructive hand transplantation: the past, present, and future in psychosocial assessment of patients undergoing reconstructive hand transplantation. Transpl Int. Epub November 14, 2013.
  • Clemens KK, Thiessen-Philbrook H, Parikh CR, et al. Psychosocial health of living kidney donors: a systematic review. Am J Transplant. 2006;6:2965–2977.
  • Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. Association among SF-36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001;12:2797–2806.
  • Kutner NG, Jassal S. Quality of life and rehabilitation of elderly dialysis patients. Semin Dial. 2002;15:107–112.
  • Kimmel PL, Emont SL, Newmann JM. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am J Kidney Dis. 2003;42:713–721.
  • Kalantar-Zadeh K, Unruh ML. Health related quality of life in patients with chronic kidney disease. Int Urol Nephrol. 2005;37:367–378.
  • Dew MA, DiMartini AF, DeVito Dabbs AJ, et al. Preventive intervention for living donor psychosocial outcomes: feasability and efficacy in a randomized controlled trial. Am J Transplant. 2013;13:2672–2684.
  • Wintner LM, Giesinger JM, Kemmler G, et al. Verwendung und Nutzen von patient-reported outcomes in der onkologischen Behandlung: eine Übersicht [The benefits of using patient-reported outcomes in cancer treatment: an overview]. Wien Klin Wochenschr. 2012;124:293–303.
  • Dew MA, Jacobs CL, Jowsey SG, Hanto R, Miller C, Delmonico FL. Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States. Am J Transplant. 2007;7:1047–1054.
  • Dew MA, Switzer GE, DiMartini A, Myaskovsky L, Crowley-Matoka M. Psychosocial aspects of living organ donation. In: Tan HP, Marcos A, Shapiro R, editors. Living Donor Transplantation. New York, NY: Informa Healthcare; 2007:7–26.
  • Goldade K, Sidhwani S, Patel S, et al. Kidney transplant patients’ perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis. 2011;57:11–20.
  • Matas AJ, Halbert RJ, Barr ML, et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant. 2002;16:113–121.
  • Kaller T, Petersen I, Petermann F, Fischer L, Grabhorn E, Schulz KH. Family strain and its relation to psychosocial dysfunction in children and adolescents after liver transplantation. Pediatr Transplant. 2014;18:851–859.
  • Pither C, Green J, Butler A, et al. Psychiatric disorders in patients undergoing intestinal transplantation. Transplant Proc. 2014;46:2136–2139.
  • Rosenberger EM, Dew MA, Crone C, DiMartini AF. Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation. Curr Opin Organ Transplant. 2012;17:188–192.
  • Timmers L, Thong M, Dekker FW, et al. Illness perceptions in dialysis patients and their association with quality of life. Psychol Health. 2008;23(6):679–690.
  • Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes. 2004;2:2.
  • Neipp M, Karavul B, Jackobs S, Meyer zu Vilsendorf A, Richter N, Becker T. Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation. 2006;81:1640–1644.
  • Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis. 2005;45:658–666.
  • Mullish BH, Kabir MS, Thursz MR, Dhar A. Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther. 2014;40:880–892.
  • Chilcot J, Spencer BW, Maple H, Mamode N. Depression and kidney transplantation. Transplantation. 2014;97:717–721.
  • Zelle DM, Dorland HF, Rosmalen JG, et al. Impact of depression on long-term outcome after renal transplantation: a prospective cohort study. Transplantation. 2012;94:1033–1040.
  • Tsunoda T, Yamashita R, Kojima Y, Takahara S. Risk factors for depression after kidney transplantation. Transplant Proc. 2010;42:1679–1681.
  • Favaro A, Gerosa G, Caforio AL, et al. Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hospital Psychiatry. 2011;33:1–7.
  • Rogal SS, Landsittel D, Surman O, Chung RT, Rutherford A. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transplant. 2011;17:251–260.
  • Thys K, Schwering KL, Siebelink M, et al. Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors, and the family: a systematic review. Transpl Int. 2015;28:270–280.
  • Mendes KD, Lopes AR, Martins TA, et al. Relevance of anxiety and stress levels on sleep quality after liver transplantation. Transplant Proc. 2014;46:1822–1826.
  • Santos GR, Boin IF, Pereira MI, et al. Anxiety levels observed in candidates for liver transplantation. Transplant Proc. 2010;42:513–516.
  • Rodrigue JR, Hanto DW, Curry MP. Substance abuse treatment and its association with relapse to alcohol use after liver transplantation. Liver Transplant. 2013;19:1387–1395.
  • Pegum N, Connor JP, Young RM, Feeney GF. Psychosocial functioning in patients with alcohol-related liver disease post liver transplantation. Addict Behav. 2015;45C:70–73.
  • Rustad JK, Stern TA, Prabhakar M, Musselman D. Risk factors for alcohol relapse following orthotopic liver transplantation: a systematic review. Psychosomatics. 2015;56:21–35.
  • Dom G, Wojnar M, Crunelle CL, et al. Assessing and treating alcohol relapse risk in liver transplantation candidates. Alcohol Alcohol. 2015;50:162–170.
  • Koljonen V, Fredrik A, Aki R, Heikki M. Self-reported alcohol use and depressive symptoms after liver transplantation. Transplantation. 2015;99(4):867–872.
  • Dobbels F, Put C, Vanhaecke J. Personality disorders: a challenge for transplantation. Prog Transplant. 2000;10:226–232.
  • Weitzner MA, Lehninger F, Sullivan D, Fields KK. Borderline personality disorder and bone marrow transplantation: ethical considerations and review. Psychooncology. 1999;8:46–54.
  • Schaubel DE, Wei G, Dykstra DM, Port FK, Merion RM. Hospitalization patterns before and after liver transplantation. Transplantation. 2007;27:1590–1594.
  • Sicard D. Ethical aspects of non-life-saving allografts with special regard to the hand. In: Lanzetta M, Dubernard JM, Petruzzo P, editors. Hand Transplantation. Milan: Springer; 2011:107–109.
  • Massey EK, Tielen M, Laging M, et al. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Transplantation. 2015;99:375–380.
  • Berben L, Denhaerynck K, Dobbels F, et al. Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study: study protocol. 2015;71:642–654.
  • Tielen M, van Exel J, Laging M, et al. Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study. J Transplant. 2014. Epub 2014 April 28.
  • Brar A, Babakhani A, Salifu MO, Jindal RM. Evaluation of non-adherence in patients undergoing dialysis and kidney transplantation: United States transplantation practice patterns survey. Transplant Proc. 2014;46:1340–1346.
  • Nevins TE, Robiner WN, Thomas W. Predictive patterns of early medication adherence in renal transplantation. Transplantation. 2014;98:878–884.
  • Massey EK, Tielen M, Laging M, et al. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. J of Psychosom Res. 2013;75:229–234.
  • Goetzmann L, Klaghofer R, Spindler A, Wagner-Huber R, Scheuer E, Buddeberg C. The “Medication Experience Scale for Immunosuppressants” (MESI): Initial results for a new screening instrument in transplant medicine. Psychother Psych Med. 2006;56:49–55.
  • Hjermstad MJ, Kaasa S. Quality of life in adult cancer patients treated with bone marrow transplantation–a review of the literature. Eur J Cancer. 1995;31a(2):163–173.
  • Jensen SE, Butt Z, Bill A, et al. Quality of life considerations in upper limb transplantation: review and future directions. J Hand Surg Am. 2012;37:2126–2135.
  • Joseph JT, Baines LS, Morris MC, Jindal RM. Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis. 2003;42(3):431–445.
  • Kniepeiss D, Wagner D, Pienaar S, et al. Solid organ transplantation: technical progress meets human dignity: a review of the literature considering elderly patients’ health related quality of life following transplantation. Ageing Res Rev. 2012;11(1):181–187.
  • Landreneau K, Lee K, Landreneau MD. Quality of life in patients undergoing hemodialysis and renal transplantation – a meta-analytic review. Nephrol Nurs J. 2010;37(1):37–44.
  • Tome S, Wells JT, Said A, Lucey MR. Quality of life after liver transplantation. A systematic review. J Hepatol. 2008;48(4):567–577.
  • Yang LS, Shan LL, Saxena A, Morris DL. Liver transplantation: a systematic review of long-term quality of life. Liver Int. 2014;34(9):1298–1313.
  • Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute; 1993.
  • Jay CL, Butt Z, Ladner DP, Skaro AI, Abecassis MM. A review of quality of life instruments used in liver transplantation. J Hepatol. 2009;51:949–959.
  • De Pasquale C, Pistorio ML, Sorbello M, et al. Body image in kidney transplantation. Transplant Proc. 2010;42:1123–1126.
  • Bradbury E. The psychological and social impact of disfigurement to the hand in children and adolescents. Dev Neurorehabil. 2007;10:143–148.
  • Schwartzer R. . Self-efficacy in the adoption and maintenance of health behaviours: theoretical approaches and a new model. In: Schwartzer E, editor. Self-Efficacy: Thought Control of Action. Washington, DC: Hemisphere; 1992:217–242.
  • Rumsey N. Body image and congenital conditions with visible differences. In: Cash TF, Pruzinsky T, editors. Body Image: A Handbook of Theory, Research, and Clinical Practice. New York, NY: Guilford; 2002:226–233.
  • Rumsey N. Optimizing body image in disfiguring congenital conditions. In: Cash TF, Pruzinsky T, editors. Body Image: A Handbook of Theory, Research, and Clinical Practice. New York, NY: Guilford; 2002:431–439.
  • Klapheke MM, Marcell C, Taliaferro G, Creamer B. Psychiatric assessment of candidates for hand transplantation. Microsurgery. 2000;20:453–457.
  • Klapheke MM. Transplantation of the human hand: psychiatric considerations. Bull Menninger Clin. 1999;63(2):159–173.
  • Kumnig M, Jowsey SG, Moreno E. Transplant psychiatry: standards in the psychosocial assessment of candidates for reconstructive hand transplantation. Paper presented at: American Society for Reconstructive Transplantation 3rd Biennial Meeting; November 15–17, 2012; The Drake Hotel, Chicago, IL.
  • Petruzzo P, Lanzetta M, Dubernard JM, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2008;86:487–492.
  • Tobin GR, Breidenbach WC, Klapheke MM, Bentley FR, Pidwell DJ, Simmons PD. Ethical considerations in the early composite tissue allograft experience: a review of the Louisville Ethics Program. Transplant Proc. 2005;37:1392–1395.
  • Simmons PD. Ethical considerations in composite tissue allotransplantation. Microsurgery. 2000;20:458–465.
  • Kalluri HV, Hardinger KL. Current state of renal transplant immunosuppression: present and future. World J Transplant. 2012;24:51–68.
  • Brouha P, Naidu D, Cunningham M, et al. Risk acceptance in composite-tissue allotransplantation reconstructive procedures. Microsurgery. 2006;26:144–150.
  • Barker JH, Allen F, Cunningham M, et al. Risk assessment and mangement in hand and facial tissue transplantation. Eur J Trauma. 2011;37:469–476.
  • Cunningham M, Majzoub R, Brouha PCR, et al. Risk acceptance in composite tissue allotransplantation reconstructive procedures: instrument design and validation. Eur J Trauma. 2004;30:12–16.
  • Lanzetta M, Nolli R, Borgonovo A, et al. Hand transplantation: ethics, immunosuppression and indications. J Hand Surg. 2001;26:511–516.
  • Majzoub RK, Cunningham M, Grossi F, Maldonado C, Banis JC, Barker JH. Investigation of risk acceptance in hand transplantation. J Hand Surg. 2006;31A:295–302.
  • NICE. Peritoneal Dialysis: Peritoneal Dialysis in the Treatment of Stage 5 Chronic Kidney Disease. NICE Clinical Guideline 125. 2011; Available from: http://www.nice.org.uk/guidance/CG125. Accessed February 24, 2014.
  • Grincenkov FR, Fernandes N, Chaoubah A, et al. Factors associated with the quality of life of incident patients on PD in Brazil (BRAZPD). J Bras Nefrol. 2011;33:38–44.
  • Balasubramanian G, McKitty K, Fan SLS. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Nephrol Dial Transplant. 2011;26:1702–1708.
  • Hautz T, Brandacher G, Zelger B, et al. Immunologic aspects and rejection in solid organ versus reconstructive transplantation. Transplant Proc. 2010;42:3347–3353.
  • Ravindra K, Wu S, McKinney M, Xu H, Ildstad ST. Composite tissue allotransplantation: current challenges. Transplant Proc. 2009;41:3519–3528.
  • Lukasczik M, Neuderth S, Köhn D, Faller H. Psychologische Aspekte der Lebendnierenspende und -transplantation: Ein Überblick zum aktuellen Forschungsstand. Z Med Psychol. 2008;17:107–123.
  • Ginieri-Coccosso M, Theofilou P, Synodinou C, Tomaras V, Soldatos C. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: investigating differences in early and later years of current treatment. BMC Nephrol. 2008;9:14–22.
  • Christensen A, Ehlers S. Psychological factors in end-stage renal disease: an emerging context for behavioral medicine research. J Consult Clin Psychol. 2002;70:712–724.
  • Griffin KW. Comparison of quality of life in haemodialysis and peritoneal dialysis patients. In: Khanna R, editor. Advances in Peritoneal Dialysis. Toronto, ON: Peritoneal Dialysis Publications; 1994.
  • Tonelli M, Wiebe N, Knoll G, et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11:2093–2109.
  • Álvares J, Cesar CC, Acurcio Fde A, Andrade EI, Cherchiglia ML. Quality of life of patients in renal replacement therapy in Brazil: comparison of treatment modalities. Qual Life Res. 2012;21:983–991.
  • Tong A, Hanson CS, Chapman JR, et al. The preferences and perspectives of nephrologists on patients’ access to kidney transplantation: a systematic review. Transplantation. 2014;15:682–691.
  • Kimmel P. Psychosocial factors in dialysis patients. Kidney Int. 2001;59:1599–1613.
  • Kutner NG, Johansen KL, Kaysen GA, et al. The comprehensive dialysis study (CDS): a USRDS special study. Clin J Am Soc Nephrol. 2009;4:645–650.
  • Rodrigue JR, Pavlakis M, Danovitch GM, Johnson SR, Karp S, Khwaja K. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US Transplant Program. Am J Transplant. 2007;7:2326–2332.
  • Manyalich M, Menjívar A, Yucetin L, et al. Living donor psychosocial assesment/follow-up practices in the partners’ countries of the ELIPSY project. Transpl Proc. 2012;44:2246–2249.
  • Lennerling A, Lovén C, Dor FJ, et al. Living organ donation practices in Europe–results from an online survey. Transpl Int. 2013;26:145–153.
  • Maldonado JR, Dubois HC, David EE, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. 2012;53(2):123–132.
  • Cherkassky L. A fair trial? Assessment of liver transplant candidates with psychiatric illnesses. Med Ethics. 2011;37:739–742.
  • Carosella ED, Pradeu T. Transplantation and identity: a dangerous split? Lancet. 2006;368:183–184.